SectorBiological Technology
Established Date04/01/2000
Listing Date25/03/2015
ExchangeNASDAQ Stock Exchange
Full-time Employees224
Fiscal Year Ends31/12
Security TypeDepository Receipts (Ordinary Shares)
Office addressCellectis S.A.
8
rue de la Croix Jarry
75013 Paris
France
Business
IntroductionCellectis S.A. was established on January 4, 2000. The company is a clinical-stage biotechnology company that leverages their core proprietary technology to develop gene-edited products with a portfolio of allogeneic chimeric antigen receptor T cells, or candidates in the field of immuno-oncology, and gene-edited hematopoietic stem cells and progenitors, or HSPC, candidates for other therapeutic indications.
